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Introduction: Brugada syndrome is a genetic disorder of the heart’s electrical system that increases 
a patient’s risk of sudden cardiac death. It is a syndrome most prevalent in Southeast Asians and is 
found 36 times more commonly in Asians than in Hispanics.
Case Report: We report and discuss a case of a 68-year-old Hispanic male who presented with 
clinical and electrocardiogram abnormalities consistent with Brugada syndrome.
Discussion: The patient’s age and ethnicity represents an atypical presentation of this rare 
syndrome and the lack of reported studies in the literature pertaining to these demographics 
reflect this.
Conclusion: Further studies and characterizations are necessary as manifestations continue to 
be unearthed. As such, Brugada Syndrome should be considered in the differential diagnosis for a 
myriad of patient populations. [Clin Pract Cases Emerg Med. 2020;4(2):251–254.] 
Keywords: syncope; ventricular tachycardia; ventricular fibrillation; emergency department; sudden 
cardiac death.
INTRODUCTION
Brugada syndrome, an autosomal dominant disorder 
of the heart’s electrical system, was first described in 
medical literature in 1992 as a frequent cause of syncope, 
ventricular tachyarrhythmia, and sudden cardiac death.2, 
3 An extremely rare phenomenon affecting an estimated 
0.05% of people worldwide, it presents at an average age 
of 41 years and tends to affect men and those of Asian 
ancestry most frequently.3, 4 The electrocardiogram (ECG) 
of a patient with this syndrome classically demonstrates 
ST-segment elevations in leads V1 to V3 and a right bundle 
branch block pattern.3 Here we discuss a case of an elderly 
Hispanic patient with no significant past medical history who 
presented to the emergency department (ED) with first-time 
signs and symptoms consistent with Brugada syndrome. 
Henry Ford Wyandotte Hospital, Department of Emergency Medicine, Wyandotte, Michigan 
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CASE REPORT
A 68-year-old Hispanic male with no significant past 
medical history was brought to the ED by emergency medical 
services (EMS) for confusion and altered mental status. EMS 
reported that they were called by the patient’s wife when she 
discovered him breathing erratically and could not rouse him. 
Upon arrival to the ED, the patient was obtunded and began 
to experience cardiac arrest with ventricular fibrillation. He 
was subsequently intubated and given Advanced Cardiac 
Life Support where cardiopulmonary resuscitation was 
administered and the patient was defibrillated. He went on 
to experience return of spontaneous circulation. An ECG 
obtained in the ED during this event demonstrated ST-segment 
elevations in V1-V3 and specific repolarization abnormalities 
in V1 and V2 (Image).
*
†
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CPC-EM Capsule
What do we already know about this clinical 
entity? 
Brugada syndrome is a rare genetic disease 
of the heart associated with arrhythmia and 
sudden cardiac death.
What makes this presentation of disease 
reportable? 
Our Hispanic patient represents an atypical 
presentation of a disease most prevalent in 
Asians and lends credence to the need for 
further evaluation of this disorder.
What is the major learning point? 
Brugada syndrome should be considered 
in the differential diagnosis for various 
patient populations.
How might this improve emergency 
medicine practice? 
Broadening the differential diagnosis  will 
aid early recognition, particularly in the 
elderly with unremarkable cardiac histories.
Additional ECG findings included the following: first-
degree atrioventricular (AV) block, PR interval of 220 
milliseconds (120-200 milliseconds), and QRS duration of 
0.11 seconds (0.08-0.12 seconds).
The patient was placed on an amiodarone infusion and 
transferred to a medical facility with a cardiac catheterization 
laboratory. Emergent cardiac catheterization was performed 
due to concerns for ST-elevation myocardial infarction 
(STEMI), but no acute findings were discovered. Laboratory 
values from the initial blood draw in the ED demonstrated 
the following: sodium 132 milliequivalent per liter (meq/L) 
(normal 136-145 meq/L); potassium 3.3meq/L (normal 3.5-
5.0 meq/L); magnesium 3.3 milligram per deciliter (mg/dL) 
(normal 1.5-2.4 mg/dL); glucose 197mg/dL; troponin <0.02 
nanograms per milliliter;  brain natriuretic peptide (BNP) 65; 
prothrombin time (PT) 13.6 seconds (normal 11-13 seconds); 
international normalized ratio (INR) 1.3 seconds; and thyroid 
stimulating hormone (TSH) 59.4 milliunits per liter (mU/L) 
(normal 0.5-5.0 mU/L). 
Following cardiac catheterization, the patient was 
transferred to the intensive care unit where all vital signs 
remained stable and within normal limits. With members 
of the patient’s immediate family at bedside, information 
pertaining to his personal history was elicited for the first time. 
They reported that the patient had been in good health prior 
to the onset of his confusion and at no point did he complain 
of any discomfort or associated symptoms. Furthermore, they 
denied any significant past medical or surgical events in the 
patient’s history, including any personal or family history 
of heart disease or sudden cardiac death. They stated that 
the patient had no allergies, did not take any medications, 
never used tobacco or illicit drugs, and consumed alcohol 
occasionally during social events. 
The following day, the patient was extubated with 
excellent response and was found to have no focal deficits 
on physical exam. Thyroid replacement therapy was initiated 
for severe hypothyroidism discovered incidentally during the 
aforementioned care. Although no additional adverse cardiac 
events would occur for the duration of his hospital stay, the 
patient agreed to placement of an implantable-cardioverter 
defibrillator (ICD) as recommended for secondary prevention 
of Brugada syndrome. 
Further work-up of the patient during his hospital 
course included the following: magnetic resonance imaging 
of the brain, which demonstrated multiple small areas of 
infarct in the bilateral cerebral hemispheres and no other 
significant findings. Computed tomography angiography 
of the head and neck were found to be normal. After 
demonstrating an ability to ambulate 300 feet with front-
wheel walker, the patient was discharged home on aspirin 
and statin medication.
Left heart catheterization was performed 18 days 
later as recommended by the patient’s electrophysiologist. 
The right coronary artery was found without stenosis or 
blockage; the left anterior descending artery was patent; 
and overall coronary circulation and left ventricular 
function were normal. These findings, coupled with the 
patient’s presenting symptoms and findings found on ECG 
in the ED, ultimately corroborated a diagnosis of Brugada 
syndrome with a type 1 pattern. 
DISCUSSION
The average age of presentation of Brugada syndrome 
is 41 years, and men are affected far more frequently than 
women (9:1 ratio).3 This syndrome is believed to affect 
0.5 per 1000 people worldwide, with Asians affected 
nine times more often than Caucasians and 36 times 
more often than Hispanics.1 All patients, regardless of 
ethnicity, are predisposed to suffering from ventricular 
tachycardia, ventricular fibrillation, and sudden cardiac 
death.3 Moreover, patients are predisposed to suffering 
from concurrent cardiac abnormalities that include right 
bundle branch block, first-degree AV block, intraventricular 
conduction delay, and sick sinus syndrome.4 
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Several mechanisms have been implicated in the 
pathophysiology of Brugada syndrome. In the inherited, 
autosomal dominant form of the syndrome, a gene mutation 
alters the structure and function of sodium ion channels 
found in the heart. Impaired ion channels prevent the flow of 
sodium into the cardiac cell, which adversely affects the heart 
rhythm.4 One proposed mechanism is through mutation of 
the SCN5A gene, which is responsible for the production of 
cardiac sodium channels. The SCN5A gene is by far the most 
commonly affected gene found in as many as 30% of affected 
individuals. Conversely, other individual gene mutations are 
responsible for less than one percent of all presentations.4  In 
the acquired form of the syndrome, exposures from drugs 
and other environmental instigators alter ion levels in the 
blood, resulting in altered cardiac conductivity.5 Implicated 
electrolyte abnormalities include hypercalcemia, as well as 
hyperkalemia and hypokalemia.5 
Diagnosis of Brugada syndrome is based on classic ECG 
findings that include ST-segment elevations in leads V1 to V3 
and right bundle branch block patterns on ECG in conjunction 
with one of the following: history of ventricular tachycardia 
or fibrillation; family history of sudden cardiac death or a 
coved pattern on ECG; or agonal breathing during sleep.3 Our 
patient’s diagnosis was corroborated by way of ventricular 
fibrillation occurring in the ED and ST-segment elevations in 
leads V1 to V3 found on ECG.3 
Unfortunately, Brugada syndrome predisposes a patient to 
a lifetime risk of sudden cardiac death, and there are currently 
no pharmacologic treatments to reduce this risk.6 Thus, ICD is 
often recommended and was the treatment modality of choice 
used in our patient. ICD has the greatest efficacy in averting 
sudden cardiac death, but the decision to use the device 
depends on the patient’s ability to tolerate it.7 If a patient 
cannot tolerate an ICD, pharmacologic therapy then serves as 
a second-line treatment modality. Pharmaceuticals can be used 
in the acute management of an arrhythmic storm, to prevent 
arrhythmia in patients with an implanted ICD requiring 
multiple shocks, and in cases where ICD implantation is 
contraindicated or not feasible – as may be the case in children 
or upon patient refusal.8 
The following drugs have been found to be of great 
benefit: quinidine, disopyramide, quinine sulphate, beta 
agonists, phosphodiesterase inhibitors, bepridil, and 
traditional Chinese medicines such as wenxin keli and 
dimethyl lithospermate B.8 In contrast, contraindicated 
drugs that serve as sodium channel blockers with the 
ability to induce cardiac arrhythmias in Brugada syndrome 
include the following: ajmaline, procainamide, flecainide, 
propafenone and pilsicainide.8 Thus, it is imperative that 
physicians maintain Brugada syndrome atop the differential 
diagnosis for patients presenting with syncope, ventricular 
fibrillation, or STEMI, so as to avoid treating presentations 
with potentially underlying Brugada syndrome with a 
contraindicated medication.
Anticipation of Brugada syndrome in a particular patient 
demographic or age group should not be expected. Although 
it rarely presents in the geriatric and Hispanic populations 
and is not well studied in these individuals, it is a life threat 
Image. Initial patient electrocardiogram obtained in the ED. Black arrows demonstrate ST-segment elevation in a coved pattern consistent 
with a Type 1 Brugada pattern.
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necessitating clarity in presentation, modes of treatment, and 
overall mortality risk for this particular patient demographic.9 
Further compounding this issue is the profound increase in 
the incidence of syncope associated with Brugada syndrome 
during the seventh decade of life.9 As the various causes 
of syncope are complex and multifactorial, a diagnosis of 
Brugada syndrome can be missed or even veiled by comorbid 
causes of syncope such as arrhythmias, AV blocks, and atrial 
fibrillation found in the elderly.9 
There have been rare reports of SCN5A gene mutation 
variants that are capable of inducing Brugada syndrome 
under hypothyroid conditions. This is explained by thyroid 
hormone affecting cardiac myocyte action potential duration 
and repolarization currents.10 It remains a possibility that 
our patient’s clinical deterioration was incited by untreated 
hypothyroidism, but the association remains unclear. Future 
studies elucidating the relationship between hypothyroidism 
and Brugada syndrome are needed.
CONCLUSION
Our patient’s age and ethnicity represent an atypical 
presentation of Brugada syndrome, and the lack of reported 
studies in the literature pertaining to this demographic reflect 
this. It is critically important to establish a diagnosis of 
Brugada syndrome in a patient lacking a personal or family 
history of this syndrome, as a first- time diagnosis in a 
single individual implicates their entire family. Furthermore, 
patients must be cautioned about the use of anesthetics, 
antihistamines, cocaine, antiarrhythmics, and psychotropic 
drugs as they have been found to provoke Brugada 
syndrome.11 Brugada syndrome’s abrupt symptomatology, 
high mortality rate, and ability to present atypically make 
this a challenging disorder to manage. It is for all of these 
reasons that Brugada syndrome will continue to serve as 
a significant life threat that emergency physicians will be 
relied upon to recognize and manage.
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